Trial intelligence / Profile preview

Hypertonic Resuscitation Following Severe Traumatic Brain Injury

NCT00316004Phase 3Terminated

Sponsor
University of Washington
Start
May 2006
Primary completion
May 2009
Modality
Polymer-based Nanoparticles, Device-based Delivery, Recombinant Proteins and Enzymes
Countries
2
01

Overview

A Phase 3 trial of hypertonic saline, hypertonic saline + dextran-70 in traumatic brain injury (TBI), sponsored by University of Washington. Started May 2006; status: terminated.

02

Drugs

hypertonic salinehypertonic saline + dextran-70
03

Conditions

traumatic brain injury (TBI)

Beyond the preview

Go deeper on NCT00316004.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00316004.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call